Skip to main content
. 2022 Jul 4;6(7):e736. doi: 10.1097/HS9.0000000000000736

Figure 2.

Figure 2.

Therapy algorithm for the calculation of the third-line DLBCL population. 1L = First-line; 2L = Second-line; 3L = Third-line ASCT = autologous stem-cell transplantation; DLBCL = diffuse large B-cell lymphoma; Em = Early mortality; HDT = high-dose (chemo) therapy ORR = overall response rate; PFS = progression-free survival PPS = postprogression survival; R-CHOP = Rituximab—cyclophosphamide, doxorubicin, vincristine, prednisolone.